FDA Launches Program to Boost Domestic Drug Manufacturing

Over 50 percent of branded drugs and nearly 70 percent of generic drugs used in the country are manufactured abroad.

The Food and Drug Administration in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

A Food and Drug Administration (FDA) initiative to cut down regulatory barriers for domestic manufacturing facilities has begun accepting requests from pharmaceutical companies to take part in its pilot phase, according to a Feb. 1 statement from the agency.

The initiative, FDA PreCheck, seeks to strengthen the pharmaceutical supply chain and increase regulatory predictability for companies, facilitate the construction of manufacturing sites in the United States, and streamline aspects of drug manufacturing.